Target intelligence / Profile preview

Candida albicans cell wall

Molecular classification
Cellular structure, Polysaccharide complex, Structural organelle
01

Overview

The Candida albicans cell wall is a dynamic, multilayered structural organelle essential for cell survival, shape, and virulence. It comprises approximately 80-90% carbohydrate and 6-25% protein by weight. The cell wall has a bilayered architecture with an inner skeletal layer and an outer layer that determines surface properties. The inner skeletal layer consists primarily of β-1,3-glucan (47-60% of cell wall) forming a fibrillar network that is covalently cross-linked with β-1,6-glucan and chitin (0.6-9% of cell wall). These structural polysaccharides provide mechanical strength and maintain cell shape. The outer layer is enriched with mannoproteins (30-40% of cell wall), which are predominantly glycosylphosphatidylinositol-modified proteins covalently linked to the skeletal polysaccharides via β-1,6-glucan bridges. The cell wall composition and organization result from a dynamic equilibrium between synthesis and remodeling of constituent polysaccharides, adapting to environmental stresses and morphological transitions. β-1,6-glucan plays a crucial interconnecting role, linking β-1,3-glucan, chitin, and mannoproteins into an integrated structure. The cell wall is not merely a protective barrier but actively participates in adhesion, immune recognition, and pathogenicity, making it a primary target for antifungal therapeutic interventions.

Other names
C. albicans cell wallCandida cell wallFungal cell wall
02

Mechanism of action

Inhibition of β-1,3-glucan synthase (disrupts cell wall integrity); Inhibition of chitin synthesis (compromises structural skeleton); Disruption of glucan-chitin cross-linking; Interference with cell wall polysaccharide biosynthesis

03

Biological functions

Structural integrity and cell shape maintenanceProtection against osmotic pressureCell wall remodeling and expansionAdhesion to host tissuesBiofilm formationHost-pathogen interactionsImmune modulationMorphological transition (yeast to hyphal forms)
04

Disease associations

Infection (candidiasis, invasive fungal infections)Opportunistic infections in immunocompromised patientsHospital-acquired infections
05

Safety considerations

Development of drug resistance through compensatory cell wall remodelingPotential for immune-mediated reactions due to exposure of immunogenic componentsCross-resistance mechanisms when targeting single cell wall components
06

Interacting drugs

Echinocandins

3 more in the full profile.

07

Biomarkers

β-1,3-glucan (used as serum biomarker for invasive fungal infections)Mannan and anti-mannan antibodiesCell wall protein antigens

Beyond the preview

Go deeper on Candida albicans cell wall.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida albicans cell wall.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call